October 23 Big Tech briefing: robot tools, cloud model choice and wellness shopping AI
Source publication date
Site published
Checked October 22, 2026 UTC / October 23 KST. Dates below refer to the original announcements or posts.
1. NVIDIA | October 21
Isaac Lab 3.0 is generally available. Agile ONE SN remains a research humanoid planned for early 2027, with Halos integration planned. Released development tools do not establish completed commercial robot deployment. [1]
2. Google Cloud and OpenAI | October 21
GPT-6 Astra, GPT-6.1 Sol and GPT-6 Luna entered private preview for selected enterprise customers. Gemini for business and Antigravity support remains forthcoming, not general availability. [2]
3. Anthropic | October 22
Anthropic announced donation of the Agent Skills name, logo, GitHub organization and domain to AAIF. This changes stewardship of an existing open standard; it is not a model launch. [3]
4. AWS and Therabody | Posted October 22; launch announcement October 21
Therabody launched Jason for product recommendations and evidence explanations, connected to Shopify cart and checkout. This is a brand-specific commerce deployment, not validation of medical advice or treatment efficacy. [4]
[1] https://nvidianews.nvidia.com/news/nvidia-advances-isaac-platform-for-general-purpose-robotics-with-new-reference-humanoid-frameworks-simulation-pipelines-and-data/
[2] https://cloud.google.com/blog/products/ai-machine-learning/google-cloud-brings-openai-models-to-customers
[3] https://www.anthropic.com/news/donating-agent-skills-to-the-agentic-ai-foundation
[4] https://press.aboutamazon.com/aws/2026/10/therabody-launches-ai-shopping-assistant-jason-with-aws-to-deliver-personalized-science-backed-recommendations-for-every-body
Summary
Four official October 21–22 reports distinguish general availability, private preview, standards governance and a deployed shopping application.
Editorial view
Editorial view: wellness companies should assess robotics development tools, model sourcing, agent standards and customer-facing automation separately, starting with actual access and operational responsibility.
Evidence and limitations
Company reports are not independent performance, safety or clinical validation. Preview eligibility, geography and timelines can change. Already published Tesla Optimus and Apple HomeView stories are excluded.